Expected earnings - Edgewise Therapeutics Inc.
Source: US Earnings Reports
Edgewise Therapeutics Inc. (EWTX) is expected to report $-0.42 for Q2 2025
Edgewise Therapeutics Inc.
NASDAQ: EWTX
EWTX Trading
15.75% G/L:
$39.055 Last:
2,691,761 Volume:
$40.60 Open:
EWTX Latest News
June 01, 2026 08:30:00 am
Edgewise Therapeutics Announces Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline
EWTX Stock Data
$3,280,862,770
54,628,112
N/A
52
N/A
Biotechnology & Life Sciences
Healthcare
US
Boulder
